SPERZEL JOHN J III

PrivateCIK: 1602618
Location

BRUNSWICK, ME

SPERZEL JOHN J III (See Remarks) sold 36.1% of their position (9.77K shares) of T2 BIOSYSTEMS, INC. on the open market

Open‑market sale worth $6.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderSPERZEL JOHN J IIICIK 1602618
IssuerT2 BIOSYSTEMS, INC.CIK 1492674
DirectorOfficer· See Remarks
Since Jan 2020
-9.77K
Net shares
Net seller
$6.2K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
22.67K acquired · 32.44K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+16K

Price / share

Trade value

% of position

360.8%
2/20/2023
4.43K20.43K

Common Stock

Direct
S · Sale

Shares

6.88K

Price / share

$0.65

Trade value

$4.47K

% of position

33.6%
2/22/2023
20.43K13.56K

Common Stock

Direct
M · Option Exercise

Shares

+6.67K

Price / share

Trade value

% of position

49.2%
2/24/2023
13.56K20.23K

Common Stock

Direct
S · Sale

Shares

2.90K

Price / share

$0.59

Trade value

$1.71K

% of position

14.3%
2/28/2023
20.23K17.33K
Total

Net shares

+12.89K

Net value

-$6.18K

Derivative Transactions2

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

16K shares

Shares

16K

Strike price

Held after

32K

Exercisable

2/20/2023

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

6.67K shares

Shares

6.67K

Strike price

Held after

6.67K

Exercisable

2/20/2023
SPERZEL JOHN J III — Insider Transaction (Form 4) Filed Mar 9, 2023 | Finecho